Literature DB >> 20186003

Comparison of colonoscopy and fecal occult blood testing as a first-line screening of colonic lesions in patients with newly diagnosed acromegaly.

F Bogazzi1, M Lombardi, I Scattina, C Urbani, E Marciano, A Costa, P Pepe, G Rossi, E Martino.   

Abstract

CONTENT: Patients with acromegaly have frequently colonic neoplasms; however, how acromegalic patients should be screened for colonic lesions is still unsettled. AIMS: To compare fecal occult blood testing (FOBT) and colonoscopy in the screening program of patients with acromegaly.
DESIGN: Colonoscopy and FOBT were performed at the first diagnosis of acromegaly.
SETTING: Tertiary University center. PATIENTS: Eighty-five consecutive patients with untreated active acromegaly submitted to colonoscopy and FOBT.
RESULTS: FOBT, which was positive in 16 (18.8%) out of 85 patients, identified 2 patients with colonic adenocarcinoma and 2 with adenoma; the remaining 12 patients had no detectable colonic lesions. Colonoscopy revealed colonic lesions in 29 patients: 3 (3.5%) cancers, 11 (12.9%) adenomas, and 15 (17.6%) hyperplastic polyps. The remaining 56 acromegalic patients had no detectable lesions. A patient with cancer and 9 patients with adenoma were missed if screened only by FOBT.
CONCLUSIONS: Colonoscopy is superior to FOBT in detecting colonic lesions at the first diagnosis of acromegaly.

Entities:  

Mesh:

Year:  2010        PMID: 20186003     DOI: 10.1007/BF03346642

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Risk of colorectal neoplasia in acromegaly: an independent view.

Authors:  W S Atkin
Journal:  Clin Endocrinol (Oxf)       Date:  2001-12       Impact factor: 3.478

Review 2.  Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?

Authors:  S Ezzat; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1991-02       Impact factor: 5.958

3.  Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.

Authors:  P J Jenkins; V Frajese; A M Jones; C Camacho-Hubner; D G Lowe; P D Fairclough; S L Chew; A B Grossman; J P Monson; G M Besser
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

4.  Apoptosis is reduced in the colonic mucosa of patients with acromegaly.

Authors:  Fausto Bogazzi; Dania Russo; Maria Teresa Locci; Barbara Chifenti; Federica Ultimieri; Francesco Raggi; Chiara Cosci; Chiara Sardella; Aurelio Costa; Maurizio Gasperi; Luigi Bartalena; Enio Martino
Journal:  Clin Endocrinol (Oxf)       Date:  2005-12       Impact factor: 3.478

5.  One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Authors:  D A Lieberman; D G Weiss
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

6.  Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Maurizio Gasperi; Renato Cozzi; Rosario Pivonello; Giovanni Vitale; Alfredo Scillitani; Roberto Attanasio; Elisabetta Cecconi; Fulvia Daffara; Ezio Gaia; Ennio Martino; Gaetano Lombardi; Alberto Angeli; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-10-26       Impact factor: 5.958

7.  Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands.

Authors:  Fausto Bogazzi; Federica Ultimieri; Francesco Raggi; Dania Russo; Renato Vanacore; Chiara Guida; Sandra Brogioni; Chiara Cosci; Maurizio Gasperi; Luigi Bartalena; Enio Martino
Journal:  Endocrinology       Date:  2004-04-07       Impact factor: 4.736

Review 8.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

9.  The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients.

Authors:  Annamaria Colao; Rosario Pivonello; Renata S Auriemma; Mariano Galdiero; Diego Ferone; Francesco Minuto; Paolo Marzullo; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

10.  Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegaly.

Authors:  S Grottoli; V Gasco; A Mainolfi; G Beccuti; G Corneli; G Aimaretti; C Dieguez; F Casanueva; E Ghigo
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

View more
  1 in total

1.  Patients with Acromegaly Presenting with Colon Cancer: A Case Series.

Authors:  Murray B Gordon; Samer Nakhle; William H Ludlam
Journal:  Case Rep Endocrinol       Date:  2016-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.